Abivax SA
PAR:ABVX
Abivax SA
PAR:ABVX
Price:
105.5
EUR
4.46%
Market Closed
Market Cap:
€8.3B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Abivax SA
PAR:ABVX
|
FR |
|
I
|
IMT Co Ltd (Gyeonggi-do)
KOSDAQ:451220
|
KR |
|
P
|
Pudo Inc
CNSX:PDO
|
CA |
|
R
|
Ruanyun Edai Technology Inc
NASDAQ:RYET
|
CN |
|
Sanofi SA
PAR:SAN
|
FR |
|
China Natural Resources Inc
NASDAQ:CHNR
|
HK |
|
D
|
Dampskibsselskabet Norden A/S
F:D69
|
DK |
|
Midi Utama Indonesia Tbk PT
IDX:MIDI
|
ID |
|
Centaurus Metals Ltd
ASX:CTM
|
AU |
|
Solutions 30 SE
PAR:S30
|
LU |
|
Kiplin Metals Inc
XTSX:KIP
|
CA |
|
Cardig Aero Services Tbk PT
IDX:CASS
|
ID |
Multiples-Based Value
The
Multiples-Based Value for
Abivax SA (ABVX)
under the Base Case is
hidden
EUR.
Compared with the current market price of 105.5 EUR, the stock appears
hidden
.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
ABVX Multiples-Based Value
LOCKED
Multiples Across Competitors
ABVX Competitors Multiples
Abivax SA Competitors
Abivax SA Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| FR |
|
Abivax SA
PAR:ABVX
|
8.3B EUR | 0 | -33.7 | -35.7 | -35.5 | |
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD | 33 690 872.8 | -160 127.7 | -194 446.1 | -192 227.3 | |
| US |
|
Abbvie Inc
NYSE:ABBV
|
374.1B USD | 6.1 | 89.7 | 14.8 | 20.6 | |
| US |
|
Amgen Inc
NASDAQ:AMGN
|
188.5B USD | 5.2 | 24.8 | 14.4 | 14.4 | |
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
175.7B USD | 6 | 20.7 | 12.9 | 16 | |
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
112.8B USD | 9.5 | 28.7 | 21.6 | 22.5 | |
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR | 2 091 | -533.6 | -581 | -565.5 | |
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
82B USD | 5.7 | 18 | 13.5 | 15.4 | |
| NL |
|
argenx SE
XBRU:ARGX
|
41.9B EUR | 11.8 | 37.9 | 40.9 | 41.8 | |
| AU |
|
CSL Ltd
ASX:CSL
|
68.5B AUD | 3 | 33.2 | 11.2 | 14 | |
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR | 20.1 | -61.8 | -66.6 | -60.1 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
